https://scholars.lib.ntu.edu.tw/handle/123456789/513430
標題: | A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: The Wingspan study | 作者: | Bose A. Hartmann M. Henkes H. HON-MAN LIU Teng M.M.H. Szikora I. Berlis A. Reul J. Yu S.C.H. Forsting M. Lui M. Lim W. Sit S.P. |
公開日期: | 2007 | 卷: | 38 | 期: | 5 | 起(迄)頁: | 1531-1537 | 來源出版物: | Stroke | 摘要: | BACKGROUND AND PURPOSE - The purpose of this study was to assess the safety and performance of the Wingspan stent system and Gateway percutaneous transluminal angioplasty balloon catheter in the treatment of high-grade, intracranial atherosclerotic lesions in patients who had failed medical therapy. METHODS - In this prospective, multicenter, single-arm study, medically refractory patients with a modified Rankin score ?3 and recurrent symptoms attributable to angiographically demonstrated intracranial stenosis ?50% in a vessel 2.5 to 4.5 mm in diameter were enrolled. Intracranial lesions were predilated with an undersized Gateway balloon catheter to 80% of the native vessel diameter, followed by deployment of the self-expanding Wingspan stent to facilitate further remodeling of the atherosclerotic plaque and to maintain vessel patency. Neurologic examinations and angiograms were performed at 6 months after the procedure. RESULTS - Among the 45 patients enrolled, the degree of stenosis was reduced from a baseline of 74.9±9.8% to 31.9±13.6% after stenting and 28±23.2% at the 6-month follow-up. The 30-day composite ipsilateral stroke/death rate was 4.5% (2/44); at the 6-month follow-up, the ipsilateral stroke/death rate was 7.0%, the rate for all strokes was 9.7%, and all-cause mortality was 2.3%. Physician-reported follow-up in 43 patients (average of 13 months) conducted outside the study protocol (not adjudicated by the clinical event committee) reported 1 additional ipsilateral stroke. CONCLUSIONS - In medically refractory patients with high-grade intracranial atherosclerotic stenoses, a new treatment paradigm involving predilation with an undersized Gateway percutaneous transluminal angioplasty balloon catheter and placement of a self-expanding Wingspan stent system appears to be safe, may facilitate remodeling, and may contribute to favorable angiographic outcomes. ? 2007 American Heart Association, Inc. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/513430 | ISSN: | 0039-2499 | DOI: | 10.1161/STROKEAHA.106.477711 | SDG/關鍵字: | acetylsalicylic acid; clopidogrel; nitinol; adverse outcome; aged; article; atherosclerotic plaque; balloon catheter; blood vessel; blood vessel diameter; brain atherosclerosis; brain damage; brain hematoma; clinical article; clinical trial; controlled clinical trial; controlled study; epiglottis edema; female; fever; follow up; heart arrhythmia; human; hyperglycemia; hypertension; hypervolemia; male; mortality; multicenter study; neurologic examination; nystagmus; percutaneous transluminal angioplasty; physician; postoperative complication; priority journal; prospective study; Rankin scale; respiratory failure; risk assessment; scoring system; stent; stroke; symptom; vascular patency; Aged; Alloys; Angioplasty, Balloon; Female; Humans; Intracranial Arteriosclerosis; Male; Prospective Studies; Stents; Treatment Outcome |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。